NIH 2008 N01 CA |
Early Therapeutics Development with Phase II Emphasis / Mayo Clinic, Rochester |
$1,546,853 |
NIH 2007 N01 CA |
Early Therapeutics Development with Phase II Emphasis Erlichman, Charles / |
$1,288,760 |
NIH 2007 N01 CA |
Early Therapeutics Development with Phase II Emphasis / |
$1,288,760 |